SEBI Circular, Notification, provisions Take over code Listing norms Corporate laws Listed Companies FII investments Stock brokers BSE NSE Mutual Funds IPO News
SEBI : Negative net worth creates major interpretational challenges under Regulation 16 of SEBI LODR Regulations. This article explains t...
SEBI : This article explains mandatory website disclosure requirements under Regulations 46 and 62 of SEBI LODR Regulations, 2015. It hig...
SEBI : SEBI introduced a uniform 30-day lag for sharing and using market price data for educational purposes after concerns over misuse o...
SEBI : This article explains the key website disclosure requirements imposed on listed companies under SEBI LODR Regulations, 2015. It hi...
SEBI : SEBI’s new circular restricts unauthorized use and redistribution of real-time exchange data by educators, finfluencers, and tra...
SEBI : SEBI has proposed major reforms to the Pre-open Call Auction mechanism after concerns over artificially suppressed prices in IPO a...
SEBI : SEBI revised the methodology for computing household savings through the securities market by incorporating actual granular data a...
SEBI : SEBI issued a draft consultation paper proposing limited relaxation of third-party payment restrictions in mutual funds for specif...
SEBI : SEBI has proposed replacing the centralized STP Hub with direct API-based connectivity between STP Service Providers to reduce lat...
SEBI : SEBI has proposed exempting Research Analysts from maintaining call recordings for institutional investors, citing their sophistic...
SEBI : The issue was whether failure to refund investor funds is time-barred. The Court held it is a continuing offence, rejecting the li...
SEBI : Calcutta High Court directs SEBI to accept Priya Ranjan Sah's payment, citing a one-day delay as not warranting prolonged litigati...
SEBI : The adjudication is conducted as per the mechanism outlined under SEBI Act and the rules framed thereunder. Notably, the provision...
SEBI : Calcutta High Court held that SEBI cannot be forced to hand over documents to the accused. Accordingly, allowing petition u/s. 91 ...
SEBI : Madras High Court dismissed the petition on the ground of availability of an effective and efficacious alternative remedy under se...
SEBI : SEBI clarified that clients under Non-Discretionary PMS can pledge securities held in their demat accounts for personal borrowing....
SEBI : SEBI has modified the Monthly Cumulative Report format for mutual funds following the introduction of new scheme categories. The r...
SEBI : SEBI issued a revised Master Circular consolidating surveillance-related directions for stock exchanges, listed companies, interme...
SEBI : SEBI issued clarifications after revised PAN application forms under the Income-tax Rules, 2026 created compliance challenges for ...
SEBI : SEBI has clarified that InvITs with borrowings exceeding 49% of asset value can use fresh debt for capital expenditure, road maint...
SEBI seeks public input on amendments to assign responsibility for AI tool usage in the securities market to protect investors’ data and ensure compliance.
SEBI allows simplified registration for FPIs by introducing an abridged Common Application Form, reducing duplication for eligible applicants.
SEBI invites public comments on the procedure for seeking a waiver or reduction of interest on penalty recovery proceedings by Dec 2, 2024.
SEBI issues updated Master Circular for ICDR Regulations, consolidating directions till September 30, 2024, with a chapter-wise compliance framework.
SEBI issues updated Master Circular for LODR Regulations, consolidating compliance provisions for listed entities, stock exchanges, and other stakeholders.
SEBI outlines the procedure for reclassifying FPI investments to FDI for holdings exceeding 10% in Indian companies, effective immediately.
SEBI mandates brokers offer trading supported by blocked funds, including UPI block or 3-in-1 trading accounts, starting February 2025.
SEBI seeks public comments on revising the UPSI definition under Insider Trading Regulations for better clarity and compliance. Deadline: November 30, 2024.
SEBI denies Glenmark Life Sciences’ request for no-action relief, stating contra trade restrictions apply to its proposed share sale for minimum public shareholding compliance.
SEBI states sale to meet public shareholding norms isn’t exempt from insider trading rules, impacting Nirma’s share sale in Glenmark Life Sciences.
